ANAHEIM, Calif., Sept. 30, 2014 /PRNewswire/ -- Headquartered in
Anaheim, California, WholeHealth
Products. (OTC: GWPC) is a diversified company comprised of several
specialized partners focused on leveraging the power and
convenience of advanced technology and the proven expertise of its
team of professionals to improve the fundamental business of health
and wellness. WholeHealth Products' line of more than 10
professional diagnostic tests for hospitals, doctors, clinics and
healthcare centers, and its more than 8 retail consumer tests is
proud to announce an addition to its line of rapid diagnostic
tests.
WholeHealth Products' R&D has discovered a specific enzyme
which has a correlation to Autism and Fragile X. The quantitative
amount of the enzyme is used to determine Autism or Fragile X in
young children, as young as infants. This lab blood test is
done using a microwell machine, giving the quantitative result; and
the test can be done in less than 30 minutes. This revolutionary
breakthrough will give parents a diagnosis they need at birth
rather than waiting 3-4 years.
WholeHealth Products has already completed a Rapid Diagnostic
version for this enzyme test, which can be used as a screening for
Autism or Fragile X, giving a qualitative result in less than 5
minutes using no machines. WholeHealth Products will be seeking FDA
marketing clearance for these new tests.
Inspired by its slogan, "Love Life Live Long,"
WholeHealth is committed to building long term relationships
with the medical and healthcare professional and the patients,
helping saves lives.
www.wholehealth-products.com
WholeHealth Products is your partner in the "Business of
Science".
Certain information set forth in this fact sheet may contain
forward-looking statements that involve substantial known and
unknown risks and uncertainties. These forward-looking statements
are subject to numerous risks and uncertainties, certain of which
are beyond the control of WholeHealth Products Inc, including, but
not limited to, risks associated with the impact of general
economic conditions, industry conditions, dependence upon
regulatory approvals, and the uncertainty of obtaining additional
financing. Readers are cautioned that the assumptions used in the
preparation of such information, although considered reasonable at
the time of preparation, may prove to be imprecise and, as such,
undue reliance should not be placed on forward-looking
statements.
Photo - http://photos.prnewswire.com/prnh/20140930/149260
SOURCE WholeHealth Products Inc.
